The days of malaria, one of Africa's main health challenges - and equally that of swathes of South and Central America and other tropical environments across the world - appears to be gradually coming to an end with the recent approval, for use, of the malaria vaccine, Mosquirix, which had undergone development and generally successful trials, in the past 28 years.
